LCTXLineage Cell Therapeutics, Inc.
1.080USD-1.82%Mkt Cap: 273.14M $P/E: —3d ago
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, a…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap273.14M $
Enterprise Value223.49M $
Revenue (TTM)13.08M $
Gross Profit14.41M $
Net Income (TTM)-63.53M $
Revenue/Share0.0540 USD
Last Price1.080 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees72
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.59
PEG10.64
EV/EBITDA-8.56
EV/Revenue17.08
P/S20.88
P/B4.48
EPS (TTM)-0.19
EPS (Forward)-0.10
52W Range
1.0007% of range2.090
52W High2.090 USD
52W Low1.000 USD
Profitability
Gross Margin99.00%
Oper. Margin-834.70%
EBITDA Margin-199.58%
Profit Margin-436.47%
ROE-142.61%
ROA-56.43%
Growth
Revenue Growth-61.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.92M $
CapEx (TTM)522.00K $
FCF Margin-112.93%
FCF Yield-5.41%
Net Debt-48.53M $
Net Debt/EBITDA1.86
Balance Sheet
Debt/Equity0.05
Current Ratio6.61
Quick Ratio6.46
Book Value/Sh0.2410 USD
Cash/Share0.2010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateOct 31, 1997
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.500 USD
Upside (mean)+409.3%
Target Range3.000 USD – 9.000 USD
$3.000+409.3% to mean$9.000
# Analysts6
Ownership
Shares Out.252.91M
Float190.89M
Insiders4.86%
Institutions48.19%
Short Interest
Short Ratio29.5d
Short % Float19.39%
Short % Out.11.69%
Shares Short29.56M
Short (prev mo.)28.19M
Technical
SMA 501.176 (-8.2%)
SMA 2001.501 (-28.1%)
Beta1.55
S&P 52W Chg19.18%
Avg Vol (30d)898.63K
Avg Vol (10d)935.11K
Technical Indicators
RSI (14)43.5
MACD-0.0277
MACD Signal-0.0315
MACD Hist.+0.0038
BB Upper1.153 USD
BB Middle1.089 USD
BB Lower1.024 USD
BB Width11.88%
ATR (14)0.0554 USD
Vol Ratio (20d)0.79x